Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 08 Mar 2018
At a glance
- Drugs Ticagrelor (Primary) ; Aspirin
- Indications Acute coronary syndromes; Coronary artery disease; Myocardial infarction
- Focus Adverse reactions
- Acronyms TWILIGHT
- 01 Mar 2018 Planned End Date changed from 1 Apr 2019 to 1 Aug 2019.
- 01 Mar 2018 Planned primary completion date changed from 1 Apr 2019 to 1 Aug 2019.
- 01 Mar 2018 Status changed from recruiting to active, no longer recruiting.